SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors anticipate earnings, with discussions focusing on potential revenue beats and updated guidance. The community is weighing the possibility of a post-earnings surge against concerns of short-term manipulation, and a few investors are citing potential rate cuts as catalysts for the stock.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets and Data Centers. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

GLXY is trending downwards amid a private offering announcement, which is causing dilution concerns among some investors despite the company's claims that the capital will strengthen financial flexibility and fund growth initiatives. The community is debating the timing and transparency of the offering, drawing comparisons to past instances of perceived insider advantages. Some traders are taking profits or considering day trading due to the volatile price action, while others view the drop as a buying opportunity based on the company's fundamentals and the value of the offering relative to the market cap.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending amid mixed sentiment, with some traders citing a potential bottom after a period of decline, while others express concerns about manipulation and the company's long-term prospects. A recent NFL apparel partnership is a key catalyst mentioned, though some question its impact, and overall discussion centers on whether the stock is poised for a rebound or further downside. Community members are actively debating analyst ratings and potential activist involvement.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as the company recently launched new AI chips aimed at competing with Nvidia and AMD in the data center market, generating significant buzz and a surge in stock price. Community discussions revolve around the potential impact of these chips, revenue projections, and whether Qualcomm can truly challenge the dominance of existing players. Some analysts express skepticism, citing the chips' specifications and disclosed customer base, while others highlight the company's shift towards AI infrastructure.

Bed Bath & Beyond, Inc. engages in the provision of an e-commerce platform. It offers furniture and home furnishing products and services. The company was founded on May 5, 1997 and is headquartered in Murray, UT.

Bed Bath & Beyond Inc.

Bed Bath & Beyond Inc

Bed Bath & Beyond ($BBBY) is trending as the company reclaims its original ticker symbol after Overstock's rebranding, sparking discussions of meme stock potential and a possible short squeeze. Community members are debating the impact of blockchain initiatives tied to tZERO and speculating about strategic moves by key figures like Ryan Cohen. Bearish investors cite concerns about dilution and cash burn while bullish investors focus on potential new directions for the company.

Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.

Celestica, Inc. - Ordinary Shares (Subordinate Voting)

Celestica, Inc.

Celestica ($CLS) is trending due to positive community sentiment and strong reactions to recent earnings, with many calling the results a "monster" beat. The community is buzzing about the company's potential, with some drawing comparisons to $NVDA and anticipating significant future growth. The stock's performance is also being discussed in the context of the broader tech sector and AI infrastructure.

Trump For President

Trump Crypto is trending amid mixed community sentiment, with some users discussing potential pumps and scams while others express political opinions related to Trump. Bullish investors are anticipating gains, while bearish investors are pointing to the coin's performance since launch. The coin seems to be moving in response to triggers related to its namesake figure.

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to a significant volume spike and discussions around its potential for a parabolic move. Community members are closely watching for continuation and a possible short squeeze, citing a very low float and insider ownership. Some traders are also pointing to a recent revenue growth update as a potential catalyst.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group (UNH) is trending as investors anticipate the company's earnings report, with some expecting a positive surprise due to lowered expectations and potential catalysts like a DOJ decision. The community is actively discussing options strategies, with some bulls hedging their bets, while others express concerns about margin pressures and potential negative impacts. Optimism remains among some, citing Warren Buffett's backing and potential for long-term growth despite near-term challenges.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as investors weigh the potential impact of a new web browser from OpenAI, a possible competitor to Google Chrome. Despite the concerns, many community members view the dip as a buying opportunity, emphasizing Google's diverse portfolio and strong position in AI and cloud computing.  Additionally, some analysts have recently raised their price targets for the stock, citing positive advertising and cloud channel checks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cyclerion Therapeutics shares jumped 47% in after-hours trading on Tuesday, placing it among the session’s top five U.S. gainers, after the company said it will relaunch with a focus on developing therapies for neuropsychiatric conditions.The plan is supported by a new licensing agreement with the Massachusetts Institute of Technology (MIT) covering intellectual property that will form the basis of its research programs.The company stated its lead program is for treatment-resistant depression (TRD) and is a combination of anesthetic agents with a proprietary delivery system to restore connectivity between regions of the brain. A Phase 2 proof-of-concept trial is expected to commence in 2026 with data anticipated in 2027.Cyclerion was spun out of Ironwood Pharmaceuticals in 2019. It raised $175 million in private investment to develop its soluble guanylate cyclase (sGC) stimulator programs.&nbsp;As part of its strategic shift since then, the company sold zagociguat and CY3018 to Tisento in 2023, out-licensed praliciguat in 2021, and entered into a license option agreement for olinciguat in 2024.“This relaunch represents a pivotal moment for Cyclerion Therapeutics as we refocus our efforts on advancing breakthrough neuropsychiatric treatments for patients who have limited therapeutic options today,” said Errol DeSouza, Chairperson of Cyclerion’s Board of Directors.CEO Regina Graul said the company plans to expand into additional neuropsychiatric diseases as it builds a pipeline of novel therapies.On Stocktwits, retail sentiment was ‘extremely bullish’ amid an 842% surge in 24-hour message volume. One bullish user called Cyclerion a strong candidate for a squeeze when regular trading resumes on Wednesday.&nbsp;<stembedurl>https://stocktwits.com/carldcarpatst/message/629757983</stembedurl>Another user stated that they had been accumulating shares over the past year, citing the MIT licensing deal as validation of the company’s potential and predicting a market cap of $100 million if further announcements follow.<stembedurl>https://stocktwits.com/AshleySchaeffer_BMW/message/629746974</stembedurl><a href="https://stocktwits.com/symbol/CYCN">Cyclerion Therapeutics’ stock</a> has declined 6.2% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cyclerion Therapeutics’ stock (CYCN) has declined 6.2% so far in 2025. (Photo credit: Getty Images)

Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today?

The biotech is relaunching as a neuropsychiatric company, anchored by an MIT licensing deal and a lead program in treatment-resistant depression.

Equity

Critical Comparison: Cyclerion Therapeutics (NASDAQ:CYCN) and Bellicum Pharmaceuticals (NASDAQ:BLCM)

Bellicum Pharmaceuticals (NASDAQ:BLCM  Get Free Report) and Cyclerion Therapeutics (NASDAQ:CYCN  Get Free Report) are both small-cap medical companies, but which is the superior stock...

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Cyclerion Therapeutics Inc

Will Alphabet ($GOOGL) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Alphabet Inc Class A

) beat quarterly earnings? 
 
*Powered by Polymarket

Current Price	$2.10
Prev Close	$2.12
Open	$2.11
Dividend Yield	0.00%
50-Day Moving Average	$2.44
Beta	0.43
Avg. Volume	1M
PE Ratio	-2.85

52-Week High	$9.47
52-Week Low	$1.27
Market Capitalization	$7.08M
EPS (Annual)	-$1.21
Price to Book	0.76
Revenue Per Employee	$2M
Enterprise Value/EBITDA	N/A

CYCN
Cyclerion Therapeutics Inc

Feed

News

Sentiment

Fundamentals

Info

Latest CYCN News

CYCNCyclerion Therapeutics Inc